Jessica Marie Posada, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Transitional Cell | 1 | 2024 | 798 | 0.580 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2024 | 2229 | 0.390 |
Why?
|
| Apolipoproteins E | 4 | 2018 | 1438 | 0.270 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 42 | 0.200 |
Why?
|
| Lipofuscin | 1 | 2020 | 44 | 0.190 |
Why?
|
| Urinary Bladder | 1 | 2024 | 1171 | 0.150 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2014 | 60 | 0.120 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 726 | 0.120 |
Why?
|
| Receptor, erbB-2 | 1 | 2024 | 2410 | 0.120 |
Why?
|
| Receptors, LDL | 2 | 2013 | 475 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 1274 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2020 | 1252 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11472 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2023 | 2986 | 0.100 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 20774 | 0.090 |
Why?
|
| Apolipoprotein E4 | 1 | 2012 | 667 | 0.080 |
Why?
|
| Genomics | 1 | 2024 | 5692 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4839 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5163 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2021 | 3456 | 0.070 |
Why?
|
| Xanthomonas vesicatoria | 1 | 2005 | 1 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2018 | 2956 | 0.070 |
Why?
|
| Atherosclerosis | 2 | 2012 | 3428 | 0.070 |
Why?
|
| Monocytes | 2 | 2013 | 2593 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5249 | 0.060 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3564 | 0.060 |
Why?
|
| Mice, Knockout | 5 | 2021 | 14554 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2019 | 4414 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 1887 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 1889 | 0.050 |
Why?
|
| Mice | 9 | 2023 | 81045 | 0.050 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 1499 | 0.050 |
Why?
|
| Leucovorin | 1 | 2023 | 624 | 0.050 |
Why?
|
| Genes, Bacterial | 1 | 2005 | 1078 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10163 | 0.050 |
Why?
|
| Losartan | 1 | 2023 | 298 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 8829 | 0.040 |
Why?
|
| Lipodystrophy | 1 | 2020 | 147 | 0.040 |
Why?
|
| Mutation | 1 | 2024 | 29717 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 4455 | 0.040 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 18006 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2023 | 1615 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7289 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 751 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 12071 | 0.040 |
Why?
|
| Animals | 9 | 2023 | 168561 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 1613 | 0.030 |
Why?
|
| Melanoma | 1 | 2014 | 5462 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2023 | 2906 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2020 | 721 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 5662 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1348 | 0.030 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2014 | 39 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2023 | 2257 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 1820 | 0.030 |
Why?
|
| Cholesterol | 2 | 2013 | 2895 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1875 | 0.030 |
Why?
|
| Benzylamines | 1 | 2014 | 226 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2021 | 1806 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 16665 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 2013 | 148 | 0.030 |
Why?
|
| Humans | 9 | 2024 | 742088 | 0.030 |
Why?
|
| Benzoates | 1 | 2014 | 217 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2715 | 0.030 |
Why?
|
| Diet, Atherogenic | 1 | 2012 | 95 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 2721 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3465 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2013 | 373 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 2011 | 121 | 0.030 |
Why?
|
| L-Selectin | 1 | 2011 | 213 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 251 | 0.020 |
Why?
|
| Disease Progression | 2 | 2020 | 13256 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17400 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1864 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 786 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 1155 | 0.020 |
Why?
|
| Female | 6 | 2023 | 379592 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 1813 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1599 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 2450 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2020 | 9144 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2005 | 143 | 0.020 |
Why?
|
| Liver | 1 | 2020 | 7470 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2014 | 1932 | 0.020 |
Why?
|
| Plant Diseases | 1 | 2005 | 150 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4438 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 21821 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 2867 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7721 | 0.010 |
Why?
|
| Macrophages | 1 | 2013 | 5655 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 19223 | 0.010 |
Why?
|
| Male | 3 | 2021 | 349538 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9715 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4742 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13814 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 18112 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23387 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40054 | 0.000 |
Why?
|